Status:
COMPLETED
Short Term, High Dose Vitamin D Supplementation for COVID-19
Lead Sponsor:
Post Graduate Institute of Medical Education and Research, Chandigarh
Conditions:
COVID
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Coronavirus-2019 (COVID-19) caused by severe acute respiratory syndrome-associated coronavirus-2 (SARS-CoV-2) has affected the lives of millions of individuals globally and severely strained the medic...
Detailed Description
The role of therapeutic vitamin D supplementation in asymptomatic individuals with vitamin-D deficiency and COVID-19 is not known. Immune-modulatory effect of vitamin D is likely to be observed at 25(...
Eligibility Criteria
Inclusion
- SARS-CoV-2 RNA positive Asymptomatic individuals
Exclusion
- Uncontrolled Diabetes Uncontrolled Hypertension Chronic Liver Disease Chronic obstructive Pulmonary disease Requiring Invasive Ventilation
Key Trial Info
Start Date :
June 15 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 10 2021
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT04459247
Start Date
June 15 2020
End Date
April 10 2021
Last Update
November 2 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Deptt of Endocrinology
Chandigarh, India, 160012